Stableford Capital II’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
2,757
+1,642
| +147% | +$785K | 0.5% | 44 |
|
|
2025
Q1 | $477K | Buy |
1,115
+1
| +0.1% | +$428 | 0.2% | 94 |
|
|
2024
Q4 | $580K | Sell |
1,114
-11
| -1% | -$5.72K | 0.23% | 103 |
|
|
2024
Q3 | $672K | Sell |
1,125
-5
| -0.4% | -$2.99K | 0.27% | 104 |
|
|
2024
Q2 | $627K | Sell |
1,130
-5
| -0.4% | -$2.78K | 0.25% | 104 |
|
|
2024
Q1 | $660K | Buy |
1,135
+2
| +0.2% | +$1.16K | 0.26% | 99 |
|
|
2023
Q4 | $619K | Buy |
+1,133
| New | +$619K | 0.27% | 93 |
|
|
2022
Q1 | – | Sell |
-1,415
| Closed | -$815K | – | 134 |
|
|
2021
Q4 | $815K | Buy |
1,415
+585
| +70% | +$337K | 0.34% | 85 |
|
|
2021
Q3 | $479K | Buy |
+830
| New | +$479K | 0.24% | 94 |
|
|
2020
Q2 | – | Sell |
-5,094
| Closed | -$1.45M | – | 79 |
|
|
2020
Q1 | $1.45M | Buy |
5,094
+1,640
| +47% | +$465K | 1% | 38 |
|
|
2019
Q4 | $1.12M | Sell |
3,454
-39
| -1% | -$12.7K | 1.02% | 29 |
|
|
2019
Q3 | $1.02M | Sell |
3,493
-156
| -4% | -$45.4K | 0.95% | 27 |
|
|
2019
Q2 | $1.07M | Sell |
3,649
-581
| -14% | -$171K | 1.04% | 25 |
|
|
2019
Q1 | $1.16M | Sell |
4,230
-339
| -7% | -$92.8K | 0.96% | 31 |
|
|
2018
Q4 | $1.02M | Sell |
4,569
-557
| -11% | -$125K | 1.09% | 29 |
|
|
2018
Q3 | $1.25M | Buy |
+5,126
| New | +$1.25M | 0.83% | 32 |
|
|
2017
Q2 | – | Sell |
-2,885
| Closed | -$443K | – | 119 |
|
|
2017
Q1 | $443K | Buy |
+2,885
| New | +$443K | 0.38% | 64 |
|